Pathogenesis and management of pruritus in cholestatic liver disease

被引：44

作者：

Imam, Mohamad H. ^{[1
]}

Gossard, Andrea A. ^{[1
]}

Sinakos, Emmanouil ^{[1
]}

Lindor, Keith D. ^{[1
]}

机构：

[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2012年 / 27卷 / 07期

关键词：

cholestatic; itch; liver; pruritus; PRIMARY BILIARY-CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; URSODEOXYCHOLIC ACID THERAPY; RANDOMIZED-CONTROLLED-TRIALS; PRIMARY BILLARY CIRRHOSIS; MU-OPIOID RECEPTORS; SERUM BILE-ACIDS; INTRAHEPATIC CHOLESTASIS; DOUBLE-BLIND; HUMAN-SKIN;

D O I：

10.1111/j.1440-1746.2012.07109.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

Patients with cholestatic liver diseases such as primary biliary cirrhosis, primary sclerosing cholangitis and intrahepatic cholestasis of pregnancy commonly complain of pruritus. The underlying pathogenesis remains obscure with several mediators possibly playing an important role; these include lysophosphatidic acid, bile salts, opioids, histamine and progesterone metabolites. We describe in this review novel insights into the pathogenesis and management of pruritus in patients with cholestasis.

引用

页码：1150 / 1158

页数：9

共 75 条

[1]

Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: Case reports [J].

Alallam, Alallam ;

Barth, David ;

Heathcote, E. Jenny .

CANADIAN JOURNAL OF GASTROENTEROLOGY, 2008, 22 (05) :505-507

[2]

Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor [J].

Ananthanarayanan, M ;

Balasubramanian, N ;

Makishima, M ;

Mangelsdorf, DJ ;

Suchy, FJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :28857-28865

[3]

Pruritus in Primary Billary Cirrhosis: Pathogenesis and Therapy [J].

Bergasa, Nora V. .

CLINICS IN LIVER DISEASE, 2008, 12 (02) :385-+

[4]

The Itch of Liver Disease [J].

Bergasa, Nora V. .

SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2011, 30 (02) :93-98

[5]

Pruritus and fatigue in primary biliary cirrhosis [J].

Bergasa, NV ;

Mehlman, JK ;

Jones, EA .

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (04) :643-655

[6]

Bergasa NV, 1996, LIVER, V16, P298

[7]

EFFECTS OF NALOXONE INFUSIONS IN PATIENTS WITH THE PRURITUS OF CHOLESTASIS - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL [J].

BERGASA, NV ;

ALLING, DW ;

TALBOT, TL ;

SWAIN, MG ;

YURDAYDIN, C ;

TURNER, ML ;

SCHMITT, JM ;

WALKER, EC ;

JONES, EA .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (03) :161-167

[8]

BERGASA NV, 2004, CURR TREAT OPTIONS G, V7, P501

[9]

Opioids and the skin - where do we stand? [J].

Bigliardi, Paul L. ;

Tobin, Desmond J. ;

Gaveriaux-Ruff, Claire ;

Bigliardi-Qi, Mei .

EXPERIMENTAL DERMATOLOGY, 2009, 18 (05) :424-430

[10]

Opioid-induced mast cell activation and vascular responses is not mediated by μ-opioid receptors:: An in vivo microdialysis study in human skin [J].

Blunk, JA ;

Schmelz, M ;

Zeck, S ;

Skov, P ;

Likar, R ;

Koppert, W .

ANESTHESIA AND ANALGESIA, 2004, 98 (02) :364-370

← 1 2 3 4 5 6 7 8 →